| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8239326 | International Journal of Radiation Oncology*Biology*Physics | 2008 | 7 Pages |
Abstract
Chemoradiotherapy could be a powerful regimen for controlling tumor progression in advanced gastric cancer, improving patients' quality of life with tolerable toxicity. A complete histologic response rate of >10% would be expected, even for large tumors with metastatic lesions.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yoshiro M.D., Ph.D., Tetsuro M.D., Ph.D., Koshi M.D., Rieko M.D., Koichiro M.D., Ph.D., Naoyuki M.D., Ph.D., Atsushi M.D., Ph.D., Masaki M.D., Ph.D., Yuko M.D., Ph.D.,